Paliperidone
Back to searchMolecule Structure
Scientific Name
Paliperidone
Description of the Drug
Paliperidone is an atypical antipsychotic used in the treatment of schizophrenia and other schizoaffective or delusional disorders.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01267
http://www.drugbank.ca/drugs/DB01267
Brand Name(s)
Invega, Paliperidone, Trevicta, Xeplion
Company Owner(s)
Cspc Ouyi Pharmaceutical Co Ltd, Sun Pharmaceutical Industries Ltd, Actavis Laboratories Fl Inc, Amneal Pharmaceuticals Of New York Llc, Rk Pharma Inc, Inventia Healthcare Ltd, Lupin Ltd, Janssen Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
| Dopamine D2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL217 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL436689 | |
| PharmGKB | PA163518919 | |
| Human Metabolome Database | HMDB0015396 | |
| DrugBank | DB01267 | |
| PubChem: Thomson Pharma | 14905143 | |
| PubChem | 115237 | |
| Mcule | MCULE-5597043685 | |
| LINCS | LSM-46209 | |
| Nikkaji | J508.304D | |
| BindingDB | 50252513 | |
| DrugCentral | 4137 | |
| ChemicalBook | CB9222359 | |
| Guide to Pharmacology | 7258 | |
| rxnorm | PALIPERIDONE | INVEGA |
| PubChem: Drugs of the Future | 22395187 | |
| ChEBI | 83804 |
